## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---
last_verified: "2026-06-28T18:35:38.837Z"
---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "Tintinalli's ER Manual"
developer_entity: "Usatine & Erickson Media LLC"
bundle_id: "com.usatineMediaLLC.tintinalliEmManual8e"
app_store_id: "1320957999"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Paid"
offline_capable: true
market_region: "US"
platforms: "iOS"
app_last_updated: "2024-03-28"
report_date: "2026-06-28"
last_verified: "2026-06-28"
report_version: "1.2"
total_reviews: 0
sentiment: "Upset"
sentiment_score: 10
confidence: "low"
confidence_score: 0.45
top_complaint_theme: "Aggressive paywall structures prevent access to core features after the initial purchase price"
review_sample_size: 1
total_review_count: 1
analyzed_review_count: 1
data_age_days: 0
intelligence_version: 3
nemesis: "UpToDate"
competitor_count: 6
tags: ["medical", "paid", "upset sentiment", "mobile app", "app review", "app analysis", "clinicians", "healthcare", "professionals"]
canonical_url: "https://marlvel.ai/intel-report/medical/tintinalli-s-er-manual"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

# Tintinalli's ER Manual App Audit

## TL;DR {#tldr}

- **Category**: Medical · Paid
- **Signal**: Sentiment Upset
- **Recent focus**: Aggressive paywall structures prevent access to core features after the initial purchase price (top complaint)

> **TL;DR:** Tintinalli's ER Manual is a medical app by Usatine & Erickson Media LLC, with Upset user sentiment (10/100), available on iOS.
>
> **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** Tintinalli's ER Manual is a medical app by Usatine & Erickson Media LLC.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **User Mood** | Upset |
| **Category** | Medical |
| **Developer** | Usatine & Erickson Media LLC |
| **Pricing** | Paid |
| **Platforms** | iOS |
| **Confidence** | Low (0.45/1.0) |
| **Data Age** | 0d |

## Metadata & Market Performance
- **Publisher:** Usatine & Erickson Media LLC
- **Category:** Medical
- **Target Audience:** Clinicians and healthcare professionals working in acute care and emergency medicine settings.
- **Platforms:** iOS
- **Version Audited:** 1.2
- **Audit Date:** 2026-06-28
- **Signal Count:** 1 reviews analyzed
- **Confidence:** Low (0.45/1.0)
- **App Store ID (iOS):** 1320957999
- **Bundle ID:** com.usatineMediaLLC.tintinalliEmManual8e
- **Performance Trend:** Declining
- **Data Window:** Analysis based on signals collected up to 2026-06-28

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** Tintinalli's ER Manual is a portable, offline-accessible clinical reference app for emergency medicine professionals on iOS.
**Why users hire it:** Clinicians hire this tool for rapid, reliable triage information in high-acuity settings where network connectivity is unreliable or unavailable.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Differentiator] Offline Content Access:** Full text and image retrieval available without an active internet connection after initial download.
  * *User Intent:* Users want uninterrupted access without internet dependency.
- **[Standard] Predictive Search:** Search tool provides suggestions as the user types and retains history for rapid retrieval of past topics.
  * *User Intent:* Users want to quickly find relevant content or features.
- **[Standard] Personalized Annotations:** Users can create notes and bookmarks for specific chapters and images.
  * *User Intent:* Users value self-expression and personalized experiences.
- **[Standard] Adaptive UI:** Layout adjusts automatically for phone or tablet screen sizes.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

The app occupies a niche professional reference space, but the lack of recent rating volume and the high price point relative to free alternatives like Merck Manual limits its market reach.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Paid
- **Tiers:** Single purchase at $49.99
- **Price:** iOS: $49.99
- **Analysis:** Paid model anchored at $49.99, positioning the app as a professional medical reference tool rather than a consumer utility.

<!-- section:sentiment -->
## 🔴 User Sentiment (Low Confidence: 1 of 1 reviews analyzed) {#user-sentiment}
- **Overall Sentiment:** Upset

### Top Complaints (Impact Areas)
- **Aggressive paywall structures prevent access to core features after the initial purchase price**

<!-- /section:sentiment -->
<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Offline-first architecture ensures utility in high-acuity clinical zones without network access.
- Personalized annotation layers increase switching costs for power users.

**Critical Frictions:**
- $49.99 initial price point combined with recurring subscription demands drives negative user sentiment.
- 100% negative sentiment trend on the latest release indicates a critical monetization failure.

**Growth Levers:**
- Pivot to an enterprise-licensing model to bypass individual clinician friction.
- Integrate clinical calculators to increase daily utility.

**Market Threats:**
- UpToDate's enterprise distribution moat effectively locks out individual-purchase apps in hospital settings.
- Free alternatives like Merck Manual erode the value proposition of paid static references.

<!-- /section:swot -->
## Recent Changes (v2 → v3) {#recent-changes}

The app's competitive position has declined due to aggressive subscription demands and a failure to address user complaints, leading to a negative sentiment trend.

**Overall trend**: Declining
**Compared at**: 2026-06-28

### High-impact changes
- **[Declined] Sentiment and Rating Collapse** (sentiment) — Overall sentiment moved from neutral to terrible, with a 100% negative complaint rate regarding subscription paywalls.
- **[Shifted] Monetization Strategy Transparency** (pricing) — Pricing model clarified as a $49.99 initial purchase followed by recurring subscription demands, which is now cited as a primary adoption barrier.

### Medium-impact changes
- **[Improved] Offline Access Differentiator** (features) — Offline content access was elevated from a standard feature to a key differentiator for high-acuity clinical settings.
- **[Added] Competitive Threat Identification** (swot) — Added Merck Manual as a primary threat due to its free, encyclopedic nature, and UpToDate as an enterprise-integrated competitor.

<!-- section:rivals -->
## Rivals Landscape {#rivals}

> Competitive positioning identified by AI analysis of app features, category, and market signals.

### Tintinalli's ER Manual vs UpToDate — Head to Head
- **[UpToDate](https://marlvel.ai/intel-report/medical/uptodate)** by UpToDate, Inc.: UpToDate is the industry-standard clinical decision support tool, serving the same professional audience as Tintinalli’s with a massive, frequently updated evidence-based repository.
  - **Moat strength:** High — sustainable advantage over 12 months
  - **Key differences:**
    - Maintains a massive, peer-reviewed clinical database that updates daily to reflect current medical evidence.
    - Offers deep integration with hospital electronic health records, creating a sticky enterprise-level distribution moat.
    - Provides comprehensive clinical calculators and drug interaction tools directly within the primary search workflow.
  - **Where Tintinalli's ER Manual wins:**
    - ✅ Delivers a highly curated, portable version of a single authoritative textbook for rapid emergency triage.
    - ✅ Offers a lower-friction, offline-first experience for clinicians in high-acuity settings without reliable network access.
  - **Where UpToDate wins:**
    - ❌ Provides a continuous, evidence-based content stream that far exceeds the static nature of a manual.
    - ❌ Leverages a massive enterprise subscription model that makes it the default choice for teaching hospitals.
  - **Verdict:** The target app must position itself as a specialized, rapid-access 'pocket companion' rather than attempting to compete with the comprehensive, enterprise-integrated clinical database of UpToDate.

### Contenders (Strong Challengers)
- **[DynaMed](https://marlvel.ai/intel-report/medical/dynamed)** by EBSCO Publishing [Moat: Medium]: DynaMed provides a direct alternative for evidence-based clinical summaries, competing for the same professional medical reference market.
  - Features a rigorous, systematic literature surveillance process that ensures clinical summaries remain current and actionable.
  - Offers a highly structured, bulleted interface designed specifically for rapid clinical decision-making at the point of care.
- **[Merck Manual Professional](https://marlvel.ai/intel-report/medical/merck-manual-professional)** by Merck & Co Inc [Moat: Medium]: A long-standing, trusted medical reference that provides comprehensive clinical information similar to the target manual's scope.
  - Provides a completely free, high-quality professional medical resource that removes all financial barriers to entry.
  - Maintains a broad, encyclopedic scope that covers internal medicine beyond the acute care focus of Tintinalli’s.

### Peers (What They Do Better)
- **[MDCalc Medical Calculator](https://marlvel.ai/intel-report/medical/mdcalc-medical-calculator)** by MD Aware, LLC: While primarily a calculator, it is an essential utility for the same emergency medicine audience and shares the same clinical workflow.
  - Focuses exclusively on clinical decision rules and scoring systems, serving as a functional utility rather than a reference.
  - Aggregates thousands of specialized calculators that are frequently used alongside the clinical content found in Tintinalli’s.
- **[VisualDx](https://marlvel.ai/intel-report/medical/com-logicalimages-visualdxmobile)** by Logical Images: Serves the same clinical audience but focuses on diagnostic decision support through visual pattern recognition.
  - Uses a unique image-based diagnostic engine to help clinicians identify dermatological and systemic conditions visually.
  - Provides a specialized diagnostic workflow that complements the text-heavy reference style of traditional medical manuals.

### New Kids on the Block (What's Innovative)
- **[Figure 1 - Medical Cases](https://marlvel.ai/intel-report/medical/figure-1-medical-cases)** by Figure 1, Inc.: High release velocity and a community-driven approach to medical education represent a modern, social-first threat to static manuals.

<!-- /section:rivals -->
<!-- section:momentum -->
## App Momentum (Steady) {#momentum}

- Updated navigation bar colors.
- Maintains static content library.

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

Tintinalli's ER Manual is a challenged medical app that is a paid app.

<!-- speakable-start -->
> **Bottom Line:** The app provides high-utility clinical content but suffers from a predatory monetization model that alienates its professional user base, so the PM must prioritize removing subscription friction to prevent total brand erosion.
<!-- speakable-end -->

**Best for:** Clinicians and healthcare professionals working in acute care and emergency medicine settings.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [PIVOT] [HIGH IMPACT] Remove the subscription paywall for existing purchasers because user sentiment is 100% negative regarding double-dipping → restore trust baseline. — *Sentiment analysis identifies the aggressive paywall as the #1 driver of negative reviews.* _(trade-off: deprioritize Pause the annual subscription revenue test — the current churn rate makes the test statistically insignificant.)_
- [ ] [INVEST] [MEDIUM IMPACT] Ship integrated clinical calculators because MDCalc is a primary competitor in the same workflow → increase daily app utility. — *Competitor analysis shows MDCalc dominates the utility space for emergency medicine clinicians.* _(trade-off: deprioritize Deprioritize the UI navigation bar color updates — utility features have higher retention impact.)_
<!-- /section:pm-actions -->

<!-- section:feature-gaps -->
### Feature Gaps vs Competitors

- Evidence-based daily updates (available in UpToDate but absent here)
- Clinical calculators (available in MDCalc but absent here)
<!-- /section:feature-gaps -->

<!-- section:outlook -->
### Outlook: Declining

The professional medical reference market is consolidating around enterprise-integrated tools that offer daily evidence updates, leaving static manuals like this one increasingly isolated. Unless the app shifts to a high-utility, calculator-integrated, or enterprise-licensed model, it will continue to lose ground to free and integrated competitors.

- 🔴 The latest update failed to address subscription complaints, which compounds the negative sentiment and prevents new user conversion.
- 🔴 Static content updates cannot compete with the daily evidence-based streams of UpToDate, leading to long-term relevance decay.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Total Reviews | 0 |
| Sentiment | Upset (10/100) |
| Confidence | Low |
| Pricing Model | Paid |
| Platforms | iOS |
| Key Features | 4 analyzed |
| Trend | Declining |
| Outlook | Declining |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **Tintinalli's ER Manual** (this app) | N/A/5 | Upset | Usatine & Erickson Media LLC |
| [VisualDx](https://marlvel.ai/intel-report/medical/com-logicalimages-visualdxmobile) | 4.4/5 | N/A | Logical Images |
| [UpToDate](https://marlvel.ai/intel-report/medical/uptodate) | 4.3/5 | Upset | UpToDate, Inc. |
| [MDCalc Medical Calculator](https://marlvel.ai/intel-report/medical/mdcalc-medical-calculator) | 4.9/5 | N/A | MD Aware, LLC |
| [Merck Manual Professional](https://marlvel.ai/intel-report/medical/merck-manual-professional) | 4.8/5 | N/A | Merck & Co Inc |
| [Figure 1 - Medical Cases](https://marlvel.ai/intel-report/medical/figure-1-medical-cases) | 4.7/5 | N/A | Figure 1, Inc. |

## Company Profile
- **Developer:** Usatine & Erickson Media LLC
- **Website:** [https://usatinemedia.com](https://usatinemedia.com)

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/tintinallis-er-manual/id1320957999?uo=4)
- **Dev Site:** [Official Website](https://usatinemedia.com)
- **Sources:** Developer website content, App store metadata, User reviews.

## Related Intel Reports
- [*VisualDx*](https://marlvel.ai/intel-report/medical/com-logicalimages-visualdxmobile) (Logical Images) — 4.4/5 Rating | N/A Sentiment
- [*UpToDate*](https://marlvel.ai/intel-report/medical/uptodate) (UpToDate, Inc.) — 4.3/5 Rating | Terrible Sentiment
- [*MDCalc Medical Calculator*](https://marlvel.ai/intel-report/medical/mdcalc-medical-calculator) (MD Aware, LLC) — 4.9/5 Rating | N/A Sentiment
- [*Merck Manual Professional*](https://marlvel.ai/intel-report/medical/merck-manual-professional) (Merck & Co Inc) — 4.8/5 Rating | N/A Sentiment
- [*Figure 1 - Medical Cases*](https://marlvel.ai/intel-report/medical/figure-1-medical-cases) (Figure 1, Inc.) — 4.7/5 Rating | N/A Sentiment
- [*DynaMed*](https://marlvel.ai/intel-report/medical/dynamed) (EBSCO Publishing) — 4.9/5 Rating | N/A Sentiment
- [*Move On with AJ*](https://marlvel.ai/intel-report/medical/move-on-with-aj) (Universal Relaxation Ltd) — 4.3/5 Rating | Positive Sentiment
- [*NYC Employees PPO Plan*](https://marlvel.ai/intel-report/medical/com-uhg-mobile-nyce) (United HealthCare Services, Inc.) — 4.6/5 Rating | N/A Sentiment
- [*DeepScribe*](https://marlvel.ai/intel-report/medical/deepscribe) (DeepScribe) — 4.0/5 Rating | N/A Sentiment
- [*FHO+ Calc*](https://marlvel.ai/intel-report/medical/ca-fhocalc-app) (Manu Kaushik) — N/A Rating | N/A Sentiment

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting.
4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.45/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 1
- **Data Sources:** user reviews, developer website, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 0 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/medical/tintinalli-s-er-manual)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.